Clinical Trial Update: Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of probiotics on gastrointestinal symptoms and immune system parameters in patients with systemic sclerosis (scler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Drugs mentioned

• Probiotic formulation

Snippet

Sponsor: Federal University of São Paulo | Conditions: Systemic Sclerosis, Scleroderma | Phase 3 | Status: UNKNOWN